- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02086292
The Influence of Lidocaine Volume on Discomfort During Administration of Local Anesthetic
September 15, 2016 updated by: Norwegian University of Science and Technology
The aim of the study is to find a simple method for pain reduction that can be used in clinical practice when administering digital nerve block with a single subcutaneous injection.
It will be investigated whether a smaller volume of lidocaine can decrease pain during injection.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Healthy volunteers will receive a single subcutaneous injection digital nerve block at the base of each ring finger.
2ml 1% lidocaine in one of the fingers, and 1 ml 2% lidocaine in the other.
After each injection, the subject will be asked to evaluate the pain on a visual analog scale (0-100 mm).
Additionally the sensibility will be tested with a Semmes-Weinstein monofilament, to evaluate if the different methods achieve desired anesthetic effect.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- Department of neuroscience, NTNU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18 - 65
Exclusion Criteria:
- regular use of analgesics
- known hypersensitivity of local anaesthetic
- renal-, heart- or liver disease
- known peripheral neuropathy or diabetes mellitus
- local infection on injection site
- circulation disorders in upper extremities (e.g. Raynaud´s phenomenon)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2 milliliter lidocaine
2 ml 1% Lidocaine in one ring finger, 1 ml 2% Lidocaine in the other ring finger
|
|
Experimental: 1 milliliter lidocaine
1 ml 1% Lidocaine in one ring finger, 2 ml 2% Lidocaine in the other ring finger
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain
Time Frame: 60 seconds
|
|
60 seconds
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Vilhjalmur Finsen, prof md, Norwegian University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
March 11, 2014
First Submitted That Met QC Criteria
March 11, 2014
First Posted (Estimate)
March 13, 2014
Study Record Updates
Last Update Posted (Estimate)
September 16, 2016
Last Update Submitted That Met QC Criteria
September 15, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Wounds and Injuries
- Wounds, Stab
- Wounds, Penetrating
- Needlestick Injuries
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- 2013/2297D
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Needlestick Injuries
-
University of California, San DiegoNational Institute on Drug Abuse (NIDA); Open Society Foundations; UCSD Center... and other collaboratorsCompletedOccupational Needlestick InjuriesMexico
-
Acibadem UniversityCompletedNeedlestick InjuriesTurkey
-
Centro de Atenção ao Assoalho PélvicoRecruitingLaxity; Skin | Skin Hyperpigmentation | Needlestick PunctureBrazil
-
Medical University of South CarolinaCompletedNeedlestick InjuriesUnited States
-
Nemera La VerpilliereCompleted
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
Hospital Universiti Sains MalaysiaActive, not recruiting
-
Medical University of South CarolinaCompletedNeedlestick Injuries | Glove PerforationsUnited States
-
HTL-Strefa S.A.Completed
-
HTL-Strefa S.A.Completed
Clinical Trials on 2 ml 1% Lidocaine
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, Germany, United States, Iceland, Canada, Poland
-
Endo PharmaceuticalsCompletedAdhesive Capsulitis | Frozen ShoulderUnited States
-
Imam Abdulrahman Bin Faisal UniversityCompleted
-
Duke UniversityWithdrawnUse of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's SurgeryUpper Eyelid SurgeryUnited States
-
Novartis PharmaceuticalsCompletedPsoriasisBelgium, Russian Federation, Germany, Spain, United States, Turkey, United Kingdom, Poland, Latvia, Iceland, Canada
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
University of Wisconsin, MadisonCompleted
-
Fu Jen Catholic UniversityRecruiting
-
Develi Devlet HastanesiUnknownAnesthesia, Local | Patient Satisfaction | Anesthesia Recovery Period | Cataract Surgery | Anesthesia; Adverse Effect | AkinesiaTurkey